Harbor Capital Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Buy
1,794
+4
+0.2% +$829 0.02% 568
2026
Q1
$402K Sell
1,790
-435
-20% -$108K 0.03% 518
2025
Q4
$536K Sell
2,225
-4
-0.2% -$1.02K 0.04% 468
2025
Q3
$610K Sell
2,229
-135
-6% -$36.9K 0.05% 423
2025
Q2
$610K Sell
2,364
-32
-1% -$7.63K 0.03% 497
2025
Q1
$536K Sell
2,396
-711
-23% -$166K 0.02% 526
2024
Q4
$711K Buy
3,107
+80
+3% +$19.3K 0.03% 500
2024
Q3
$739K Buy
3,027
+10
+0.3% +$2.23K 0.03% 507
2024
Q2
$578K Buy
3,017
+12
+0.4% +$2.44K 0.04% 495
2024
Q1
$595K Buy
3,005
+339
+13% +$62.1K 0.08% 337
2023
Q4
$459K Buy
2,666
+22
+0.8% +$3.38K 0.09% 253
2023
Q3
$391K Hold
2,644
0.08% 261
2023
Q2
$578K Hold
2,644
0.12% 211
2023
Q1
$579K Buy
+2,644
New +$574K 0.17% 126

Other funds holding RMD

Harbor Capital Advisors's RMD Position: Q2 2026 in Review

Harbor Capital Advisors increased its ResMed (RMD) stake by 0.22% in Q2 2026, buying an estimated $829 and bringing the position to 1,794 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #568.

Harbor Capital Advisors first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $739K in Q3 2024. 539 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Harbor Capital Advisors held 1,794 shares of ResMed worth $350K as of Q2 2026.
  • Harbor Capital Advisors bought 4 ResMed shares in Q2 2026, an estimated $829.
  • ResMed made up 0.02% of Harbor Capital Advisors's portfolio in Q2 2026, its #568 holding.
  • Harbor Capital Advisors first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
  • Harbor Capital Advisors's ResMed position peaked at $739K in Q3 2024.
  • 539 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.